European Archives - Page 548 of 1196 - European Medical Journal

Season finale: MMR and vaccines past, present and future

As Helena and Marc wrap up this season, they’re joined by Mike Watson, CEO of Mevox, to discuss past present and future of vaccines.

Sanofi Genzyme’s Bill Sibold on preventing future health inequities

Sanofi’s Bill Sibold shares his tips on reducing time to market for pharmaceutical drugs, public perceptions of the industry after COVID-19 and more.

ABPI wins prestigious PIF TICK status

The Association of the British Pharmaceutical Industry (ABPI) has been awarded PIF TICK trusted healthcare information creator status by the Patient Information Forum, in recognition of its commitment to providing clear, accurate information for patients and the public

You've Got A Friend in GP

In this episode, Jonathan and Keith Hopcroft discuss the role of the GP in the modern world, and changes to continuity of care.

Recommendations For Better Patient Outcomes in LDL-C Management

This EMJ podcast explores the vital topic of low-density lipoprotein cholesterol (LDL-C) management in relation to the treatment and prevention of atherosclerotic cardiovascular disease. Our host, George Cooper, is joined by Michal Vrablík.

Rheumaology 9.1 Feature Image

EULAR 2022 Abstract Highlights

The following highlights spotlight several fascinating and timely abstracts presented at the European Alliance of Associations for…

Rheumaology 9.1 Feature Image

Review of the European Alliance of Associations for Rheumatology (EULAR) 2022 Congress

A NEW and innovative hybrid format was adopted for the European Alliance of Associations for Rheumatology (EULAR) 2022 Congress, allowing…

Rheumaology 9.1 Feature Image

EMJ Rheumatology 9.1 2022

Welcome to our latest issue of EMJ Rheumatology, sharing innovative case studies and research on the latest medical developments in the field. Featured articles include a review of the current understanding of metabolic syndrome, and an article summarising the functions and regulations of Type I interferons in the pathogenesis of Sjögren’s syndrome. The eJournal issue also reviews the fantastic EULAR 2022 Congress, and highlights key takeaway points.

Immune Relevant Behavioural Interventions:

Behavioural interventions and immunologic indicators of health, disease activity, and immune function are discrete subject areas

Rheumaology 9.1 Feature Image

Difficult-to-Treat Rheumatoid Arthritis

At this year’s European Alliance of Associations for Rheumatology (EULAR) Congress, taking place on 1st–4th June, Jacob van Laar Professor…